Viking Fund Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Viking Fund Management's BMY Position: Q3 2026 in Review
Viking Fund Management reduced its Bristol-Myers Squibb (BMY) stake by 16% in Q3 2026, selling an estimated $4.42M and leaving 373,000 shares worth $23.3M. The position accounts for 2.04% of the portfolio, ranked #7.
Viking Fund Management first reported a position in BMY in Q3 2019 and has held it in 22 quarters since. The position peaked at $25.5M in Q2 2026. 2,569 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Viking Fund Management held 373,000 shares of Bristol-Myers Squibb worth $23.3M as of Q3 2026.
- Viking Fund Management sold 70,000 Bristol-Myers Squibb shares in Q3 2026, an estimated $4.42M.
- Bristol-Myers Squibb made up 2.04% of Viking Fund Management's portfolio in Q3 2026, its #7 holding.
- Viking Fund Management first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 22 quarters since.
- Viking Fund Management's Bristol-Myers Squibb position peaked at $25.5M in Q2 2026.
- 2,569 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Viking Fund Management's 13F filing for Q3 2026, filed 14 Oct 2026.